Influence of Nutritional Indices on the Prognosis of Patients With SARS-CoV-2 Infection

Sponsor
Juan Kang (Other)
Overall Status
Recruiting
CT.gov ID
NCT05835102
Collaborator
(none)
800
1
5.9
134.5

Study Details

Study Description

Brief Summary

With the decline of virulence after the mutation of the SARS-CoV-2 , based on the national life and health and national development needs, the domestic SARS-CoV-2 infection epidemic prevention policy has changed, and the number of people infected by the SARS-CoV-2 has increased. Nutritional status is an indicator of human health and plays an important role in fighting disease. Malnutrition has been found to correlate with prognosis in patients infected with the SARS-CoV-2 infection . Timely identification and assessment of the patient's nutritional status and early implementation of relevant nutritional intervention are conducive to the recovery of the patient's condition.

In clinical practice, it is necessary to improve nutrition as an aspect of the comprehensive diagnosis and treatment of patients with SARS-CoV-2 infection, but there is still a lack of relevant nutritional indicators or models to simply and accurately assess the nutritional status of patients.The purpose of this study was to evaluate the effects of PNI, NRI, GNRI, albumin level, vitamin D, chest muscle area and density on the clinical characteristics and prognosis of patients with SARS-CoV-2 infection, to find the nutritional predictors of severe disease in patients with SARS-CoV-2 infection, and to establish a simpler and more accurate nutritional evaluation model. To provide evidence for targeted nutritional interventions in patients with SARS-CoV-2 infection.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients with SARS-CoV-2 infection attending the Second Affiliated Hospital of Chongqing Medical University were included in the retrospective study. Participants met the inclusion and exclusion criteria. Data to be collected include age, sex, height, and weight at initial treatment; Blood routine, liver function, kidney function, coagulation function, electrolytes, vitamin D, C-reactive protein, ferritin; CT and MRI information; Underlying diseases, complications, treatment options, etc. Follow up patients until discharge or death. After the data collection, statistical methods such as chi-square test and logistic regression analysis were used to evaluate the impact of nutritional factors on the prognosis of patients infected with SARS-CoV-2 infection.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    800 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Study on the Influence of Nutritional Indices on the Prognosis of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Actual Study Start Date :
    Feb 1, 2023
    Anticipated Primary Completion Date :
    Jul 1, 2023
    Anticipated Study Completion Date :
    Aug 1, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Patients With SARS-CoV-2 Infection

    Patients who test positive for SARS-CoV-2 nucleic acid or SARS-CoV-2 antigen

    Outcome Measures

    Primary Outcome Measures

    1. Death [October 2022 to January 2023]

      Death due to Respiratory failure or other diseases

    2. cure [October 2022 to January 2023]

      the patients with SARS-CoV-2 infection are cured and discharged from hospital

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Patients with a positive SARS-CoV-2 nucleic acid test or a positive SARS-CoV-2 antigen test.

    Exclusion Criteria:
    1. People with end-stage malignant tumors;

    2. Nutritional intake disorders, mainly dependent on enteral and parenteral nutrition supporters;

    3. paralyzed;

    4. Intravenous drug addicts.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Second Affiliated Hospital of Chongqing Medical University Chongqing Chongqing China 400000

    Sponsors and Collaborators

    • Juan Kang

    Investigators

    • Study Chair: Juan Kang, M.D., The Second Affiliated Hospital of Chongqing Medical University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Juan Kang, associate professor, The Second Affiliated Hospital of Chongqing Medical University
    ClinicalTrials.gov Identifier:
    NCT05835102
    Other Study ID Numbers:
    • 2023-19
    First Posted:
    Apr 28, 2023
    Last Update Posted:
    Apr 28, 2023
    Last Verified:
    Apr 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Juan Kang, associate professor, The Second Affiliated Hospital of Chongqing Medical University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 28, 2023